Summaries
UKHSA management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
UKHSA IPC for seasonal respiratory infections guideline
Covering the infection prevention and control principles required to prevent transmission of COVID-19 and other respiratory viruses for winter 2021–2022
UKHSA COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
NICE managing COVID-19 guideline
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
COVID-19 rapid guideline on COPD
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.
COVID-19 rapid guideline on severe asthma
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.